These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes. Breivogel CS, Selley DE, Childers SR. J Neurochem; 1997 Apr; 68(4):1462-72. PubMed ID: 9084416 [Abstract] [Full Text] [Related]
13. Immunoprecipitation of opioid receptor-Go-protein complexes using specific GTP-binding-protein antisera. Georgoussi Z, Milligan G, Zioudrou C. Biochem J; 1995 Feb 15; 306 ( Pt 1)(Pt 1):71-5. PubMed ID: 7864831 [Abstract] [Full Text] [Related]
14. Characterization of opioid receptors in cultured neurons. Vaysse PJ, Zukin RS, Fields KL, Kessler JA. J Neurochem; 1990 Aug 15; 55(2):624-31. PubMed ID: 2164573 [Abstract] [Full Text] [Related]
15. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain. Mansour A, Lewis ME, Khachaturian H, Akil H, Watson SJ. Brain Res; 1986 Dec 03; 399(1):69-79. PubMed ID: 3026574 [Abstract] [Full Text] [Related]
17. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice. Narita M, Mizoguchi H, Narita M, Sora I, Uhl GR, Tseng LF. Br J Pharmacol; 1999 Jan 03; 126(2):451-6. PubMed ID: 10077238 [Abstract] [Full Text] [Related]
18. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Traynor JR, Nahorski SR. Mol Pharmacol; 1995 Apr 03; 47(4):848-54. PubMed ID: 7723747 [Abstract] [Full Text] [Related]